Skip to main content
Top
Published in: American Journal of Clinical Dermatology 4/2002

01-06-2002 | Review Article

Helicobacter pylori Infection in Skin Diseases

A Critical Appraisal

Authors: Assistant Professor Bettina Wedi, Alexander Kapp

Published in: American Journal of Clinical Dermatology | Issue 4/2002

Login to get access

Abstract

More than 50% of the human population have long-term Helicobacter pylori infection, causing, in some cases, severe diseases such as peptic ulcers and stomach cancer. In the last few years several extra-gastrointestinal disorders have been associated with H. pylori infection. This review summarized the current medical literature, identified through hand searching and MEDLINE research, including our own studies, with regard to H. pylori and skin diseases.
From the literature it can be seen that the role of H. pylori in skin diseases is still a controversial subject. Randomized controlled trials with adequate masking and sample sizes are still lacking. The best evidence comes from studies investigating chronic urticaria in which chronic urticaria disappeared in many patients with H. pylori infection after careful eradication of the H. pylori. Moreover, there are promising recent reports of beneficial H. pylori eradication in Behçet’s disease, pruritus cutaneus, prurigo chronica, prurigo nodularis and in some patients with lichen planus, but not in rosacea or psoriasis. Before any conclusions with respect to other skin diseases such as atopic dermatitis, Schoenlein-Henoch Purpura, Sweet’s syndrome, Sjögren syndrome or systemic sclerosis may be drawn, additional randomized, double-blinded and placebo-controlled studies including adequate diagnostic schedules, sufficient eradication treatment protocols, confirmation of eradication and adequate control groups are needed.
The cutaneous pathology of H. pylori is far from being clear, but it is speculated that the systemic effects may involve increased mucosal permeability to alimentary antigens, immunomodulation, an autoimmune mechanism or the impairment of vascular integrity.
Literature
1.
go back to reference Sipponen P., Kosunen T.U., Samloff I.M., et al. Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up. Scand J Gastroenterol 1996; 31: 229–332PubMedCrossRef Sipponen P., Kosunen T.U., Samloff I.M., et al. Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up. Scand J Gastroenterol 1996; 31: 229–332PubMedCrossRef
2.
go back to reference Fallone C.A. Determinants of ethnic or geographical differences in infectivity and transmissibility of Helicobacter pylori. Can J Gastroenterol 1999; 13: 251–255PubMed Fallone C.A. Determinants of ethnic or geographical differences in infectivity and transmissibility of Helicobacter pylori. Can J Gastroenterol 1999; 13: 251–255PubMed
3.
go back to reference Xiang Z., Censini S., Bayeli P.F., et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 1995; 63: 94–98PubMed Xiang Z., Censini S., Bayeli P.F., et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 1995; 63: 94–98PubMed
4.
go back to reference Crump M., Gospodarowicz M., Shepherd F.A. Lymphoma of the gastrointestinal tract. Semin Oncol 1999; 26: 324–337PubMed Crump M., Gospodarowicz M., Shepherd F.A. Lymphoma of the gastrointestinal tract. Semin Oncol 1999; 26: 324–337PubMed
5.
go back to reference Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiologic studies. Aliment Pharmacol Ther 1999; 13: 851–856PubMedCrossRef Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiologic studies. Aliment Pharmacol Ther 1999; 13: 851–856PubMedCrossRef
6.
go back to reference Isaacson P.G. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 1999; 36: 139–147PubMed Isaacson P.G. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 1999; 36: 139–147PubMed
7.
8.
go back to reference Nedrud J.G., Czinn S.J. Helicobacter pylori. Curr Opin Gastroenterol 1997; 13: 71–78CrossRef Nedrud J.G., Czinn S.J. Helicobacter pylori. Curr Opin Gastroenterol 1997; 13: 71–78CrossRef
9.
go back to reference Go M.F. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997; 113 (6 Suppl.): S15–S20PubMedCrossRef Go M.F. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997; 113 (6 Suppl.): S15–S20PubMedCrossRef
10.
go back to reference Montecucco C., Rappuoli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol 2001; 2: 457–466PubMedCrossRef Montecucco C., Rappuoli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol 2001; 2: 457–466PubMedCrossRef
11.
go back to reference Wallace J.L. Possible mechanisms and mediators of gastritis associated with Helicobacter pylori infection. Scand J Gastroenterol 1991; 187: 65–70CrossRef Wallace J.L. Possible mechanisms and mediators of gastritis associated with Helicobacter pylori infection. Scand J Gastroenterol 1991; 187: 65–70CrossRef
12.
go back to reference Elizalde J.I., Gomez J., Panes J., et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997; 100: 996–1005PubMedCrossRef Elizalde J.I., Gomez J., Panes J., et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997; 100: 996–1005PubMedCrossRef
13.
go back to reference Kikuchi T., Kato K., Ohara S., et al. The relationship between persistent secretion of RANTES and residual infiltration of eosinophils and memory T lymphocytes after Helicobacter pylori eradication. J Pathol 2000; 192: 243–250PubMedCrossRef Kikuchi T., Kato K., Ohara S., et al. The relationship between persistent secretion of RANTES and residual infiltration of eosinophils and memory T lymphocytes after Helicobacter pylori eradication. J Pathol 2000; 192: 243–250PubMedCrossRef
14.
go back to reference Karttunen T.J., Niemela S., Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig Dis Sci 1996; 41: 1332–1336PubMedCrossRef Karttunen T.J., Niemela S., Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig Dis Sci 1996; 41: 1332–1336PubMedCrossRef
15.
go back to reference Faller G., Kirchner T. Role of antigastric autoantibodies in chronic Helicobacter pylori infection. Microsc Res Tech 2000; 48: 321–326PubMedCrossRef Faller G., Kirchner T. Role of antigastric autoantibodies in chronic Helicobacter pylori infection. Microsc Res Tech 2000; 48: 321–326PubMedCrossRef
16.
go back to reference Gasbarrini A., Franceschi F., Armuzzi A., et al. Extradigestive manifestations of helicobacter pylori gastric infection. Gut 1999; 45 Suppl. 1: I9–I12PubMedCrossRef Gasbarrini A., Franceschi F., Armuzzi A., et al. Extradigestive manifestations of helicobacter pylori gastric infection. Gut 1999; 45 Suppl. 1: I9–I12PubMedCrossRef
17.
go back to reference Negrini R., Savio A., Poiesi C., et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655–665PubMedCrossRef Negrini R., Savio A., Poiesi C., et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655–665PubMedCrossRef
18.
go back to reference Fukuda Y., Bamba H., Okui M., et al. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion 2001; 63: 93–96PubMedCrossRef Fukuda Y., Bamba H., Okui M., et al. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion 2001; 63: 93–96PubMedCrossRef
19.
go back to reference Matricardi P.M., Rosmini F., Riondino S., et al. Exposure to food-borne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000; 320: 412–417PubMedCrossRef Matricardi P.M., Rosmini F., Riondino S., et al. Exposure to food-borne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000; 320: 412–417PubMedCrossRef
20.
go back to reference Leontiadis G.I., Sharma V.K., Howden C.W. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 1999; 159: 925–940PubMedCrossRef Leontiadis G.I., Sharma V.K., Howden C.W. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 1999; 159: 925–940PubMedCrossRef
21.
go back to reference Realdi G., Dore M.P., Fastame L. Extradigestive manifestations of Helicobacter pylori infection: fact and fiction. Dig Dis Sci 1999; 44: 229–236PubMedCrossRef Realdi G., Dore M.P., Fastame L. Extradigestive manifestations of Helicobacter pylori infection: fact and fiction. Dig Dis Sci 1999; 44: 229–236PubMedCrossRef
22.
go back to reference Crabtree J.E., O’Mahony S., Wyatt J.I., et al. Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis. J Clin Pathol 1992; 45: 597–600PubMedCrossRef Crabtree J.E., O’Mahony S., Wyatt J.I., et al. Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis. J Clin Pathol 1992; 45: 597–600PubMedCrossRef
23.
go back to reference Avci O., Ellidokuz E., Simsek I., et al. Helicobacter pylori and Behçet’s disease. Dermatology 1999; 199: 140–143PubMedCrossRef Avci O., Ellidokuz E., Simsek I., et al. Helicobacter pylori and Behçet’s disease. Dermatology 1999; 199: 140–143PubMedCrossRef
24.
go back to reference Jones M.P., Knable Jr A.L., White M.J., et al. Helicobacter pylori in rosacea: lack of an association [letter]. Arch Dermatol 1998; 134: 511PubMedCrossRef Jones M.P., Knable Jr A.L., White M.J., et al. Helicobacter pylori in rosacea: lack of an association [letter]. Arch Dermatol 1998; 134: 511PubMedCrossRef
25.
go back to reference Yazawa N., Fujimoto M., Kikuchi K., et al. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 1998; 25: 650–653PubMed Yazawa N., Fujimoto M., Kikuchi K., et al. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 1998; 25: 650–653PubMed
26.
go back to reference Rothenbacher D., Bode G., Winz T., et al. Helicobacter pylori in out-patients of a general practitioner: prevalence and determinants of current infection. Epidemiol Infect 1997; 119: 151–157PubMedCrossRef Rothenbacher D., Bode G., Winz T., et al. Helicobacter pylori in out-patients of a general practitioner: prevalence and determinants of current infection. Epidemiol Infect 1997; 119: 151–157PubMedCrossRef
27.
go back to reference Breuer T., Sudhop T., Hoch J., et al. Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany. Eur J Gastroenterol Hepatol 1996; 8: 47–52PubMedCrossRef Breuer T., Sudhop T., Hoch J., et al. Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany. Eur J Gastroenterol Hepatol 1996; 8: 47–52PubMedCrossRef
28.
go back to reference Wedi B., Wagner S., Werfel T., et al. Prevalence of Helicobacter pylori associated gastritis in chronic urticaria. Int Arch Allergy Immunol 1998; 116: 288–294PubMedCrossRef Wedi B., Wagner S., Werfel T., et al. Prevalence of Helicobacter pylori associated gastritis in chronic urticaria. Int Arch Allergy Immunol 1998; 116: 288–294PubMedCrossRef
29.
go back to reference Tebbe B., Geilen C.C., Schulzke J.D., et al. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 1996; 34: 685–686PubMedCrossRef Tebbe B., Geilen C.C., Schulzke J.D., et al. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 1996; 34: 685–686PubMedCrossRef
30.
go back to reference Dominici P., Bellentani S., Di Biase A.R., et al. Familial clustering of Helicobacter pylori infection: population based study. BMJ 1999; 319: 537–541PubMedCrossRef Dominici P., Bellentani S., Di Biase A.R., et al. Familial clustering of Helicobacter pylori infection: population based study. BMJ 1999; 319: 537–541PubMedCrossRef
31.
go back to reference Valsecchi R., Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol 1998; 78: 440–442PubMedCrossRef Valsecchi R., Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol 1998; 78: 440–442PubMedCrossRef
32.
go back to reference Rebora A., Drago F., Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol 1994; 89: 1603–1604PubMed Rebora A., Drago F., Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol 1994; 89: 1603–1604PubMed
33.
go back to reference Stone M.A., Patel H., Panja K.K., et al. Results of Helicobacter pylori screening and eradication in a multi-ethnic community in central England. Eur J Gastroenterol Hepatol 1998; 10: 957–962PubMedCrossRef Stone M.A., Patel H., Panja K.K., et al. Results of Helicobacter pylori screening and eradication in a multi-ethnic community in central England. Eur J Gastroenterol Hepatol 1998; 10: 957–962PubMedCrossRef
34.
go back to reference Kosunen T.U., Aromaa A., Knekt P., et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997; 119: 29–34PubMedCrossRef Kosunen T.U., Aromaa A., Knekt P., et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997; 119: 29–34PubMedCrossRef
35.
go back to reference Collin P., Karvonen A.L., Korpela M., et al. Gastritis classified in accordance with the Sidney system in patients with primary Sjögren’s syndrome. Scand J Gastroenterol 1997; 32: 108–111PubMedCrossRef Collin P., Karvonen A.L., Korpela M., et al. Gastritis classified in accordance with the Sidney system in patients with primary Sjögren’s syndrome. Scand J Gastroenterol 1997; 32: 108–111PubMedCrossRef
36.
go back to reference Us D., Hascelik G. Seroprevalance of Helicobacter pylori infection in an asymptomatic Turkish population. J Infect 1998; 37: 148–150PubMedCrossRef Us D., Hascelik G. Seroprevalance of Helicobacter pylori infection in an asymptomatic Turkish population. J Infect 1998; 37: 148–150PubMedCrossRef
37.
go back to reference Utas S., Özbakir Ö, Turasan A., et al. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 1999; 40: 433–435PubMedCrossRef Utas S., Özbakir Ö, Turasan A., et al. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 1999; 40: 433–435PubMedCrossRef
38.
go back to reference Hyams K.C., Tylor D.N., Gray G.C., et al. The risk of Helicobacter pylori infection among U.S. military personnel deployed outside the United States. Am J Trop Med Hyg 1995; 52: 109–112PubMed Hyams K.C., Tylor D.N., Gray G.C., et al. The risk of Helicobacter pylori infection among U.S. military personnel deployed outside the United States. Am J Trop Med Hyg 1995; 52: 109–112PubMed
39.
go back to reference Bamford J.T.M., Tilden R.L., Blankush J.L., et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999; 135: 659–663PubMedCrossRef Bamford J.T.M., Tilden R.L., Blankush J.L., et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999; 135: 659–663PubMedCrossRef
40.
go back to reference Sharma V.K., Lynn A., Kaminski M., et al. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol 1998; 93: 220–222PubMedCrossRef Sharma V.K., Lynn A., Kaminski M., et al. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol 1998; 93: 220–222PubMedCrossRef
41.
go back to reference Halasz C.L.G. Helicobacter pylori antibodies in patients with psoriasis. Arch Dermatol 1996; 132: 95–96PubMedCrossRef Halasz C.L.G. Helicobacter pylori antibodies in patients with psoriasis. Arch Dermatol 1996; 132: 95–96PubMedCrossRef
42.
go back to reference Fujisawa T., Kumagai T., Akamatsu T., et al. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol 1999; 94: 2094–2099PubMedCrossRef Fujisawa T., Kumagai T., Akamatsu T., et al. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol 1999; 94: 2094–2099PubMedCrossRef
43.
go back to reference O’Donnell B.F., Lawlor F., Simpson J., et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197–201PubMedCrossRef O’Donnell B.F., Lawlor F., Simpson J., et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197–201PubMedCrossRef
44.
go back to reference Poon E., Seed P.T., Greaves M.W., et al. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140: 667–671PubMedCrossRef Poon E., Seed P.T., Greaves M.W., et al. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140: 667–671PubMedCrossRef
45.
go back to reference Champion R.H., Roberts S.O., Carpenter R.G., et al. Urticaria and angio-oedema: a review of 554 patients. Br J Dermatol 1969; 81: 588–597PubMedCrossRef Champion R.H., Roberts S.O., Carpenter R.G., et al. Urticaria and angio-oedema: a review of 554 patients. Br J Dermatol 1969; 81: 588–597PubMedCrossRef
46.
go back to reference Kontou-Fili K., Borici-Mazi R., Kapp A., et al. Physical urticaria: classification and diagnostic guidelines: an EAACI position paper. Allergy 1997; 52: 504–513PubMedCrossRef Kontou-Fili K., Borici-Mazi R., Kapp A., et al. Physical urticaria: classification and diagnostic guidelines: an EAACI position paper. Allergy 1997; 52: 504–513PubMedCrossRef
47.
go back to reference Charlesworth E.N. Urticaria and angioedema: a clinical spectrum. Ann Allergy Asthma Immunol 1996; 76: 484–495PubMedCrossRef Charlesworth E.N. Urticaria and angioedema: a clinical spectrum. Ann Allergy Asthma Immunol 1996; 76: 484–495PubMedCrossRef
48.
go back to reference Paul E., Dominante G. Diagnosis of chronic urticaria: a critical analysis of the results, based on catamnestic investigations. Z Hautkr 1988; 63: 917–925PubMed Paul E., Dominante G. Diagnosis of chronic urticaria: a critical analysis of the results, based on catamnestic investigations. Z Hautkr 1988; 63: 917–925PubMed
49.
go back to reference Watson R.D., Gershwin M.E. Acquired angioedema associated with sinusitis. J Investig Allergol Clin Immunol 2000; 10: 129–134PubMed Watson R.D., Gershwin M.E. Acquired angioedema associated with sinusitis. J Investig Allergol Clin Immunol 2000; 10: 129–134PubMed
50.
go back to reference Henz B.M., Zuberbier T. Most chronic urticaria is food-dependent, and not idiopathic. Exp Dermatol 1998; 7: 139–142PubMedCrossRef Henz B.M., Zuberbier T. Most chronic urticaria is food-dependent, and not idiopathic. Exp Dermatol 1998; 7: 139–142PubMedCrossRef
51.
go back to reference Wedi B., Elsner J., Kapp A. In vitro diagnosis of pseudoallergic reactions: new aspects. Allergy Clin Immunol Int 1996; 8: 113–115 Wedi B., Elsner J., Kapp A. In vitro diagnosis of pseudoallergic reactions: new aspects. Allergy Clin Immunol Int 1996; 8: 113–115
52.
go back to reference Zuberbier T., Chantraine-Hess S., Hartmann K., et al. Pseudoallergen-free diet in the treatment of chronic urticaria: a prospective study. Acta Derm Venereol 1995; 75: 484–487PubMed Zuberbier T., Chantraine-Hess S., Hartmann K., et al. Pseudoallergen-free diet in the treatment of chronic urticaria: a prospective study. Acta Derm Venereol 1995; 75: 484–487PubMed
53.
54.
go back to reference Leznoff A., Sussman G.L. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66–71PubMedCrossRef Leznoff A., Sussman G.L. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66–71PubMedCrossRef
55.
go back to reference Rumbyrt J.S., Katz J.L., Schocket A.L. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995; 96: 901–905PubMedCrossRef Rumbyrt J.S., Katz J.L., Schocket A.L. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995; 96: 901–905PubMedCrossRef
56.
go back to reference Hide M., Francis D.M., Grattan C.E., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599–1604PubMedCrossRef Hide M., Francis D.M., Grattan C.E., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599–1604PubMedCrossRef
57.
go back to reference Marone G., Spadaro G., Palumbo C., et al. The anti-IgE/anti-FcεRIα autoantibody network in allergic and autoimmune diseases. Clin Exp Allergy 1999; 29: 17–27PubMedCrossRef Marone G., Spadaro G., Palumbo C., et al. The anti-IgE/anti-FcεRIα autoantibody network in allergic and autoimmune diseases. Clin Exp Allergy 1999; 29: 17–27PubMedCrossRef
58.
go back to reference Ferrer M., Kinet J.P., Kaplan A.P. Comparative studies of functional and binding assays for IgG anti-Fc (epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998; 101: 672–676PubMedCrossRef Ferrer M., Kinet J.P., Kaplan A.P. Comparative studies of functional and binding assays for IgG anti-Fc (epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998; 101: 672–676PubMedCrossRef
59.
go back to reference Niimi N., Francis D.M., Kermani F., et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996; 106: 1001–1006PubMedCrossRef Niimi N., Francis D.M., Kermani F., et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996; 106: 1001–1006PubMedCrossRef
60.
go back to reference Fiebiger E., Hammerschmid F., Stingl G., et al. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship. J Clin Invest 1998; 101: 243–251PubMedCrossRef Fiebiger E., Hammerschmid F., Stingl G., et al. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship. J Clin Invest 1998; 101: 243–251PubMedCrossRef
61.
go back to reference Grattan C.E.H., Hamon C.G.B., Cowan M.A., et al. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol 1988; 119: 179–184PubMedCrossRef Grattan C.E.H., Hamon C.G.B., Cowan M.A., et al. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol 1988; 119: 179–184PubMedCrossRef
62.
go back to reference Wedi B., Novacovic V., Koerner M., et al. Chronic urticaria serum induces histamine release, leukotriene production and basophil CD63 surface expression: inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105: 552–560PubMedCrossRef Wedi B., Novacovic V., Koerner M., et al. Chronic urticaria serum induces histamine release, leukotriene production and basophil CD63 surface expression: inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105: 552–560PubMedCrossRef
63.
go back to reference Fagiolo U., Kricek F., Ruf C., et al. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000; 106: 567–572PubMedCrossRef Fagiolo U., Kricek F., Ruf C., et al. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000; 106: 567–572PubMedCrossRef
64.
go back to reference Horn M.P., Gerster T., Ochensberger B., et al. Human anti-FcεRIα autoantibodiesisolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999; 29: 1139–1148PubMedCrossRef Horn M.P., Gerster T., Ochensberger B., et al. Human anti-FcεRIα autoantibodiesisolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999; 29: 1139–1148PubMedCrossRef
65.
go back to reference Schrutka-Koelbl C., Wasilewicz-Stephani G., Gschwantler M., et al. Has eradication therapy an effect in Helicobacter-positive patients with chronic urticaria? Am J Gastroenterol 1998; 93: 2632–2633PubMedCrossRef Schrutka-Koelbl C., Wasilewicz-Stephani G., Gschwantler M., et al. Has eradication therapy an effect in Helicobacter-positive patients with chronic urticaria? Am J Gastroenterol 1998; 93: 2632–2633PubMedCrossRef
66.
go back to reference Schnyder B., Helbling A., Pichler W.J. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999; 119: 60–63PubMedCrossRef Schnyder B., Helbling A., Pichler W.J. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999; 119: 60–63PubMedCrossRef
67.
go back to reference Wolle K., Nilius M., Leodolter A., et al. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis 1998; 17: 519–521PubMed Wolle K., Nilius M., Leodolter A., et al. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis 1998; 17: 519–521PubMed
68.
go back to reference Ling T.K., Cheng A.F., Sung J.J., et al. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter 1996; 1: 57–61PubMedCrossRef Ling T.K., Cheng A.F., Sung J.J., et al. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter 1996; 1: 57–61PubMedCrossRef
69.
go back to reference Sakurane M., Shiotani A., Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. J Dermatol 2002; 29: 23–27PubMed Sakurane M., Shiotani A., Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. J Dermatol 2002; 29: 23–27PubMed
70.
go back to reference Shiotani A., Okada K., Yanaoka K., et al. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001; 6: 60–65PubMedCrossRef Shiotani A., Okada K., Yanaoka K., et al. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001; 6: 60–65PubMedCrossRef
71.
go back to reference Kolibásová K., Cervenková D., Hegyi E., et al. Helicobacter pylori: a possible etiologic factor of chronic urticaria. Dermatosen 1994; 42: 235–236 Kolibásová K., Cervenková D., Hegyi E., et al. Helicobacter pylori: a possible etiologic factor of chronic urticaria. Dermatosen 1994; 42: 235–236
72.
go back to reference Kalas D., Pronai L., Ferenczi K., et al. Connection between Helicobacter pylori infection and chronic gastrointestinal urticaria [in Hungarian]. Orv Hetil 1996; 137: 1969–1972PubMed Kalas D., Pronai L., Ferenczi K., et al. Connection between Helicobacter pylori infection and chronic gastrointestinal urticaria [in Hungarian]. Orv Hetil 1996; 137: 1969–1972PubMed
73.
go back to reference Di Campli C., Gasbarrini A., Nucera E., et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998; 43: 1226–1229PubMedCrossRef Di Campli C., Gasbarrini A., Nucera E., et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998; 43: 1226–1229PubMedCrossRef
74.
go back to reference Wustlich S., Brehler R., Luger T.A., et al. Helicobacter pylori as a possible bacterial focus of chronic urticaria. Dermatology 1999; 198: 130–132PubMedCrossRef Wustlich S., Brehler R., Luger T.A., et al. Helicobacter pylori as a possible bacterial focus of chronic urticaria. Dermatology 1999; 198: 130–132PubMedCrossRef
75.
go back to reference Daudén E, Jiménez-Alonso I., Garcia-Diez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol 2000; 39: 446–452PubMedCrossRef Daudén E, Jiménez-Alonso I., Garcia-Diez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol 2000; 39: 446–452PubMedCrossRef
76.
go back to reference Özkaya-Bayazit E., Demir K., Özguroglu E., et al. Helicobacter pylori eradication in patients with chronic urticaria. Arch Dermatol 1998; 134: 1165–1166PubMedCrossRef Özkaya-Bayazit E., Demir K., Özguroglu E., et al. Helicobacter pylori eradication in patients with chronic urticaria. Arch Dermatol 1998; 134: 1165–1166PubMedCrossRef
77.
go back to reference Peitz E., Hackelsberger A., Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs 1999; 57: 905–920PubMedCrossRef Peitz E., Hackelsberger A., Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs 1999; 57: 905–920PubMedCrossRef
78.
go back to reference Neri S., Ierna D., D’Amico R.A., et al. Helicobacter pylori and prurigo nodularis. Hepatogastroenterology 1999; 46: 2269–2272PubMed Neri S., Ierna D., D’Amico R.A., et al. Helicobacter pylori and prurigo nodularis. Hepatogastroenterology 1999; 46: 2269–2272PubMed
79.
go back to reference Daudén E., Vasquez-Carrasco M.A., Penas P.F., et al. Association of Helicobacter pylori infection with psoriasis and lichen planus: prevalence and effect of eradication therapy. Arch Dermatol 2000; 136: 1275–1276PubMedCrossRef Daudén E., Vasquez-Carrasco M.A., Penas P.F., et al. Association of Helicobacter pylori infection with psoriasis and lichen planus: prevalence and effect of eradication therapy. Arch Dermatol 2000; 136: 1275–1276PubMedCrossRef
80.
go back to reference Herr H., You C.H. Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci 2000; 15: 551–554PubMed Herr H., You C.H. Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci 2000; 15: 551–554PubMed
81.
go back to reference Rais M., Unzeitig J., Grant J.A. Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection. J Allergy Clin Immunol 1999; 103: 713–714PubMedCrossRef Rais M., Unzeitig J., Grant J.A. Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection. J Allergy Clin Immunol 1999; 103: 713–714PubMedCrossRef
82.
go back to reference Farkas H., Gyeney L., Majthenyi P., et al. Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol 1999; 37: 513–518PubMed Farkas H., Gyeney L., Majthenyi P., et al. Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol 1999; 37: 513–518PubMed
83.
go back to reference Murakami K., Fujikoka T., Nishizono A., et al. Atopic dermatitis successfully treated by eradication of Helicobacter pylori. J Gastroenterol 1996; 31: 77–82PubMedCrossRef Murakami K., Fujikoka T., Nishizono A., et al. Atopic dermatitis successfully treated by eradication of Helicobacter pylori. J Gastroenterol 1996; 31: 77–82PubMedCrossRef
84.
go back to reference Reinauer S., Megahed M., Goerz G., et al. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 1995; 33: 876–879PubMedCrossRef Reinauer S., Megahed M., Goerz G., et al. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 1995; 33: 876–879PubMedCrossRef
85.
go back to reference Machet L., Vaillant L., Machet M.C., et al. Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection [letter]. Dermatology 1997; 194 (1): 86PubMedCrossRef Machet L., Vaillant L., Machet M.C., et al. Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection [letter]. Dermatology 1997; 194 (1): 86PubMedCrossRef
86.
go back to reference Mozrzymas R., D’Amore E.S., Montini G., et al. Schonlein-Henoch vasculitis and chronic Helicobacter pylori associated gastritis and duodenal ulcer: a case report. Pediatr Med Chir 1997; 19: 467–468PubMed Mozrzymas R., D’Amore E.S., Montini G., et al. Schonlein-Henoch vasculitis and chronic Helicobacter pylori associated gastritis and duodenal ulcer: a case report. Pediatr Med Chir 1997; 19: 467–468PubMed
87.
go back to reference Cecchi R., Torelli E. Schonlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. J Dermatol 1998; 25: 482–484PubMed Cecchi R., Torelli E. Schonlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. J Dermatol 1998; 25: 482–484PubMed
88.
go back to reference Kurkcuoglu N., Aksoy F. Sweet’s syndrome associated with Helicobacter pylori infection. J Am Acad Dermatol 1997; 37: 123–124PubMedCrossRef Kurkcuoglu N., Aksoy F. Sweet’s syndrome associated with Helicobacter pylori infection. J Am Acad Dermatol 1997; 37: 123–124PubMedCrossRef
89.
go back to reference Reinauer S., Goerz G., Ruzicka T., et al. Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication. Acta Derm Venereol 1994; 74: 361–363PubMed Reinauer S., Goerz G., Ruzicka T., et al. Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication. Acta Derm Venereol 1994; 74: 361–363PubMed
90.
go back to reference Figura N., Giordano N., Burroni D., et al. Sjögren’s syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6: 321–322 Figura N., Giordano N., Burroni D., et al. Sjögren’s syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6: 321–322
91.
go back to reference Boren T., Falk P., Roth L.A., et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892–1895PubMedCrossRef Boren T., Falk P., Roth L.A., et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892–1895PubMedCrossRef
92.
go back to reference Ilver D., Arnqvist A., Ogren J., et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373–377PubMedCrossRef Ilver D., Arnqvist A., Ogren J., et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373–377PubMedCrossRef
93.
go back to reference Censini S., Lange C., Xiang Z., et al. Cag, a pathogenicity island of Helicobacter pylori encodes type-I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648–14653PubMedCrossRef Censini S., Lange C., Xiang Z., et al. Cag, a pathogenicity island of Helicobacter pylori encodes type-I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648–14653PubMedCrossRef
94.
go back to reference Del Giudice G., Covacci A., Telford J.L., et al. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001; 19: 523–563PubMedCrossRef Del Giudice G., Covacci A., Telford J.L., et al. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001; 19: 523–563PubMedCrossRef
95.
go back to reference Bagchi D., Bhattacharya G., Stohs S.J. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 1996; 24: 439–450PubMedCrossRef Bagchi D., Bhattacharya G., Stohs S.J. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 1996; 24: 439–450PubMedCrossRef
96.
go back to reference Crabtree J.E., Farmery S.M., Lindley I.J., et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 945–950PubMedCrossRef Crabtree J.E., Farmery S.M., Lindley I.J., et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 945–950PubMedCrossRef
97.
go back to reference Wagner S., Haruma K., Gladziwa U., et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 1994; 89: 1211–1218PubMed Wagner S., Haruma K., Gladziwa U., et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 1994; 89: 1211–1218PubMed
98.
go back to reference Engstrand L., Gustavsson S., Schwan A., et al. Local and systemic immune response in Helicobacter pylori-associated chronic gastritis before and after treatment. Scand J Gastroenterol 1993; 28: 1105–1111PubMedCrossRef Engstrand L., Gustavsson S., Schwan A., et al. Local and systemic immune response in Helicobacter pylori-associated chronic gastritis before and after treatment. Scand J Gastroenterol 1993; 28: 1105–1111PubMedCrossRef
99.
go back to reference Satoh K., Kimura K., Yoshida Y., et al. Relationship between Helicobacter pylori colonization and acute inflammation of the duodenal mucosa. Am J Gastroenterol 1993; 88: 360–363PubMed Satoh K., Kimura K., Yoshida Y., et al. Relationship between Helicobacter pylori colonization and acute inflammation of the duodenal mucosa. Am J Gastroenterol 1993; 88: 360–363PubMed
100.
go back to reference Yoshida N., Granger D.N., Evans D.J., et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993; 105: 1431–1440PubMedCrossRef Yoshida N., Granger D.N., Evans D.J., et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993; 105: 1431–1440PubMedCrossRef
101.
go back to reference Lutton D.A., Bamford K.B., O’Loughlin B., et al. Modulatory action of Helicobacter pylori on histamine release from mast cells and basophils in vitro. J Med Microbiol 1995; 42: 386–393PubMedCrossRef Lutton D.A., Bamford K.B., O’Loughlin B., et al. Modulatory action of Helicobacter pylori on histamine release from mast cells and basophils in vitro. J Med Microbiol 1995; 42: 386–393PubMedCrossRef
102.
go back to reference Geis G., Leying H., Suerbaum S., et al. Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori. J Clin Microbiol 1990; 28: 930–932PubMed Geis G., Leying H., Suerbaum S., et al. Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori. J Clin Microbiol 1990; 28: 930–932PubMed
103.
go back to reference Aceti A., Celestino D., Caferro M., et al. Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis. Gastroenterology 1991; 101: 131–137PubMed Aceti A., Celestino D., Caferro M., et al. Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis. Gastroenterology 1991; 101: 131–137PubMed
104.
go back to reference Leung D.Y.M., Hauk P., Strickland I., et al. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol 1998; 139: 17–29PubMedCrossRef Leung D.Y.M., Hauk P., Strickland I., et al. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol 1998; 139: 17–29PubMedCrossRef
105.
go back to reference Gasbarrini A., Serricchio M., Tondi P., et al. Helicobacter pylori infection and vascular disease. Ital J Gastroenterol Hepatol 1998; 30 Suppl. 3: S307–S309PubMed Gasbarrini A., Serricchio M., Tondi P., et al. Helicobacter pylori infection and vascular disease. Ital J Gastroenterol Hepatol 1998; 30 Suppl. 3: S307–S309PubMed
106.
go back to reference Kurose I., Granger D.N., Evans Jr D.J., et al. Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells, and platelets. Gastroenterology 1994; 107: 70–79PubMed Kurose I., Granger D.N., Evans Jr D.J., et al. Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells, and platelets. Gastroenterology 1994; 107: 70–79PubMed
107.
go back to reference Zito F., Di Castelnuovo A., D’Orazio A., et al. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999; 82: 14–18PubMed Zito F., Di Castelnuovo A., D’Orazio A., et al. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999; 82: 14–18PubMed
108.
go back to reference Hizal M., Tuzun B., Wolf R., et al. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 2000; 39: 443–445PubMedCrossRef Hizal M., Tuzun B., Wolf R., et al. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 2000; 39: 443–445PubMedCrossRef
109.
go back to reference Liekenbröcker T., Koerner M., Kapp A., et al. Correlation of infect-associated chronic urticaria with positive autologous serum skin test. Allergologie 2001; 24: 475–479 Liekenbröcker T., Koerner M., Kapp A., et al. Correlation of infect-associated chronic urticaria with positive autologous serum skin test. Allergologie 2001; 24: 475–479
110.
go back to reference Jones A.C., Logan R.P., Foynes S., et al. A flagellar sheat protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGFS cells. J Bacteriol 1997; 179: 5643–5647PubMed Jones A.C., Logan R.P., Foynes S., et al. A flagellar sheat protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGFS cells. J Bacteriol 1997; 179: 5643–5647PubMed
111.
go back to reference Valkonen K.H., Wadstrom T., Moran A.P. Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane laminin. Infect Immun 1994; 62: 3640–3648PubMed Valkonen K.H., Wadstrom T., Moran A.P. Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane laminin. Infect Immun 1994; 62: 3640–3648PubMed
112.
go back to reference Solnick J.V., Schauer D.B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev 2001; 14: 59–97PubMedCrossRef Solnick J.V., Schauer D.B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev 2001; 14: 59–97PubMedCrossRef
Metadata
Title
Helicobacter pylori Infection in Skin Diseases
A Critical Appraisal
Authors
Assistant Professor Bettina Wedi
Alexander Kapp
Publication date
01-06-2002
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 4/2002
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200203040-00005

Other articles of this Issue 4/2002

American Journal of Clinical Dermatology 4/2002 Go to the issue

Therapy in Practice

Basal Cell Carcinoma

Therapy in Practice

Photosensitivity Disorders